Open Access

Poster session 1 - Understanding the pulmonary circulation

Event: ESC CONGRESS 2017
Topic: Miscellaneous
Session type: Poster Session
Date: 26 August 2017

Session

14 presentations in this session

Increased central venous pressure is provoked not by pulmonary-circulation defects but by mild cardiac-strains in patients after Fontan procedure.

Speaker: Doctor Y. Hamamichi (Tokyo, JP)
Thumbnail

Different hemodynamic profiles to exercise in COPD and IPF candidates to lung transplantation: role of the pulmonary arterial stiffness

Speaker: Professor E. Peris Domingo (Barcelona, ES)
Thumbnail

High-density lipoprotein cholesterol level as a predictor of long-term vasoreactivity in patients with idiopathic pulmonary arterial hypertension

Speaker: Doctor K. Jonas (Krakow, PL)
Thumbnail

ACE gene subtypes and pulmonary hypertension among patients with chronic obstructive pulmonary disease

Speaker: Associate Professor C. Martiniuc (Chisinau, MD)
Thumbnail

Mitochondrial permeability transition pore blocker prevents right ventricular mitochondrial damage in monocrtaline-induced pulmonary hypertension

Speaker: Doctor D. Lee (Kyeongju, KR)
Thumbnail

Abnormalities in platelet volume and count as predictors of thrombosis and bleeding in patients with Eisenmenger syndrome

Speaker: Doctor A. Martin Garcia (Salamanca, ES)
Thumbnail

Peak oxygen consumption in chronic thromboembolic pulmonary vascular disease is determined predominately by cardiac reserve and not by dead space ventilation.

Speaker: Doctor M. Claeys (Brugge, BE)
Thumbnail

BMP2 induces DUSP1 in pulmonary artery smooth muscle cells

Speaker: Doctor H. Maruyama (Tsuchiura, JP)
Thumbnail

The selective rho kinase inhibitor trans-6-((4-aminocyclohexyl)amino)-5-fluoro-2-methoxynicotinamide ameliorates monocrotaline-induced pulmonary hypertension

Speaker: Doctor S. Cantoni (Parma, IT)
Thumbnail

National institutes of health model compared with pulmonary hypertension connection and French registry equations provides a more realistic nine-year survival estimates

Speaker: Doctor O. Akbal (Istanbul, TR)
Thumbnail

14 speakers from this session

Doctor Yuji Hamamichi

Sakakibara Memorial Hospital , Tokyo (Japan)
0 follower

Professor Enrique Peris Domingo

University Hospital Vall d'Hebron, Barcelona (Spain)
0 follower

Doctor Kamil Jonas

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)
0 follower

Associate Professor Constantin Martiniuc

Research Institute of Phthysiopulmonology ,,Chiril Draganiuc, Chisinau (Moldova (Republic of))
0 follower

Doctor Dong -Seok Lee

Dongguk University Hospital, Kyeongju (Korea (Republic of))
0 follower

Doctor Agustin Carlos Martin Garcia

University of Salamanca, Salamanca (Spain)
0 follower

Doctor Mathias Claeys

St-Jan Hospital, Brugge (Belgium)
2 presentations
0 follower

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)
0 follower

Doctor Silvia Cantoni

Chiesi Farmaceutici S.p.A., Parma (Italy)
0 follower

Doctor Ozgur Akbal

, Istanbul (Turkey)
0 follower

Doctor Hidekazu Maruyama

National Hospital Organization Kasumigaura Medical Center, Tsuchiura (Japan)
0 follower

Doctor Max-Paul Winter

Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna (Austria)
0 follower

Professor Sivadasanpillai Harikrishnan

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST), Trivandrum (India)
2 presentations
0 follower

Doctor Emre Demir

Ege University, Izmir (Turkey)
0 follower

This platform is supported by

logo Novo Nordisk